These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 27725586)

  • 1. [Pathogenesis of paroxysmal nocturnal hemoglobinuria].
    Murakami Y
    Rinsho Ketsueki; 2016; 57(10):1900-1907. PubMed ID: 27725586
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxysmal nocturnal hemoglobinuria: insights from recent advances in molecular biology.
    Bessler M; Schaefer A; Keller P
    Transfus Med Rev; 2001 Oct; 15(4):255-67. PubMed ID: 11668433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights Into the Emergence of Paroxysmal Nocturnal Hemoglobinuria.
    Colden MA; Kumar S; Munkhbileg B; Babushok DV
    Front Immunol; 2021; 12():830172. PubMed ID: 35154088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular genetics, biochemistry, and biology of PNH].
    Kinoshita T
    Rinsho Ketsueki; 2017; 58(4):353-362. PubMed ID: 28484166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycosyl phosphatidylinositol (GPI)-anchored molecules and the pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Boccuni P; Del Vecchio L; Di Noto R; Rotoli B
    Crit Rev Oncol Hematol; 2000 Jan; 33(1):25-43. PubMed ID: 10714960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement and inflammasome overactivation mediates paroxysmal nocturnal hemoglobinuria with autoinflammation.
    Höchsmann B; Murakami Y; Osato M; Knaus A; Kawamoto M; Inoue N; Hirata T; Murata S; Anliker M; Eggermann T; Jäger M; Floettmann R; Höllein A; Murase S; Ueda Y; Nishimura JI; Kanakura Y; Kohara N; Schrezenmeier H; Krawitz PM; Kinoshita T
    J Clin Invest; 2019 Dec; 129(12):5123-5136. PubMed ID: 31430258
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycosylphosphatidylinositol-anchor-deficient mice: implications for clonal dominance of mutant cells in paroxysmal nocturnal hemoglobinuria.
    Kawagoe K; Kitamura D; Okabe M; Taniuchi I; Ikawa M; Watanabe T; Kinoshita T; Takeda J
    Blood; 1996 May; 87(9):3600-6. PubMed ID: 8611683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paroxysmal nocturnal hemoglobinuria (PNH) and primary p.Cys89Tyr mutation in CD59: Differences and similarities.
    Mevorach D
    Mol Immunol; 2015 Sep; 67(1):51-5. PubMed ID: 25818314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical roundtable monograph: Paroxysmal nocturnal hemoglobinuria: a case-based discussion.
    Szer J; Hill A; Weitz IC
    Clin Adv Hematol Oncol; 2012 Nov; 10(11 Suppl 21):1-16. PubMed ID: 23271156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxysmal nocturnal hemoglobinuria: An acquired genetic disease.
    Nishimura J; Murakami Y; Kinoshita T
    Am J Hematol; 1999 Nov; 62(3):175-82. PubMed ID: 10539884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Advances in research for pathogenesis of paroxysmal nocturnal hemoglobinuria].
    Murakami Y
    Rinsho Ketsueki; 2021; 62(8):944-953. PubMed ID: 34497235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paroxysmal nocturnal haemoglobinuria.
    Hill A; DeZern AE; Kinoshita T; Brodsky RA
    Nat Rev Dis Primers; 2017 May; 3():17028. PubMed ID: 28516949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paroxysmal nocturnal hemoglobinuria.
    Brodsky RA
    Blood; 2014 Oct; 124(18):2804-11. PubMed ID: 25237200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into molecular pathogenesis of bone marrow failure in paroxysmal nocturnal hemoglobinuria.
    Kawaguchi T; Nakakuma H
    Int J Hematol; 2007 Jul; 86(1):27-32. PubMed ID: 17675263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Paroxysmal nocturnal hemoglobinuria without GPI-anchor deficiency.
    Brodsky RA
    J Clin Invest; 2019 Dec; 129(12):5074-5076. PubMed ID: 31638602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Paroxysmal nocturnal hemoglobinuria and thrombosis in the era of eculizumab].
    Nishimura JI
    Rinsho Ketsueki; 2018; 59(8):1042-1047. PubMed ID: 30185704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new aspect of the molecular pathogenesis of paroxysmal nocturnal hemoglobinuria.
    Shichishima T; Noji H
    Hematology; 2002 Aug; 7(4):211-27. PubMed ID: 14972783
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paroxysmal nocturnal hemoglobinuria: molecular pathogenesis and molecular therapeutic approaches.
    Nishimura J; Smith CA; Phillips KL; Ware RE; Rosse WF
    Hematopathol Mol Hematol; 1998; 11(3-4):119-46. PubMed ID: 9844822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Paroxysmal nocturnal hemoglobinuria (PNH). Pathogenesis, diagnosis and treatment].
    Röth A; Dührsen U; Schrezenmeier H; Schubert J
    Dtsch Med Wochenschr; 2009 Feb; 134(9):404-9. PubMed ID: 19224425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylphosphatidylinositol (GPI)-anchored membrane proteins in clinical pathophysiology of paroxysmal nocturnal hemoglobinuria (PNH).
    Shichishima T
    Fukushima J Med Sci; 1995 Jun; 41(1):1-13. PubMed ID: 8606038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.